May 15, 2023 / 04:00AM GMT
Presentation
May 15, 2023 / 04:00AM GMT
=====================
Corporate Participants
=====================
* Hiroshi Nomura
Sumitomo Pharma Co., Ltd. - CEO, President & Representative Director
* Naoki Noguchi
Sumitomo Pharma America Holdings, Inc. - Director of Business Development
* Toru Kimura
Sumitomo Pharma Co., Ltd. - EVP Global Corporate Stgy,Fin&Acc,Regenerative & Cellular Medicine Off. and Representive Director
* Yoshiharu Ikeda
Sumitomo Pharma Co., Ltd. - Senior Executive Officer of Drug Research Division, Head of Japan Business Unit and Director
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kasumi Haruta
Crédit Suisse AG, Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
* Yuto Yoshida
================
Sumitomo Pharma Co Ltd
(STU:DPM)
€
6.46
-0.34 (-5.07%)
Market Cap: 3.04 Bil
Enterprise Value: 3.94 Bil
PE Ratio: 4.59
PB Ratio: 1.67
GF Score: 71/100 Full Year 2023 Sumitomo Pharma Co Ltd Earnings Presentation Transcript
May 15, 2023 / 04:00AM GMT
Release Date Price:
€5.3
(+0.95%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot